Benzinga | Aug 12, 2020 06:34AM EDT

Beam Therapeutics Q2 EPS $(0.69) Up From $(3.38) YoY

Beam Therapeutics (NASDAQ:BEAM) reported quarterly losses of $(0.69) per share. This is a 79.59 percent increase over losses of $(3.38) per share from the same period last year.